Insider Trading History of Odink Debra

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Odink Debra since 2010. The trader's CIK number is 1281719. At the time of the last reporting, Odink Debra was the VP, Pharmaceutical R&D of Anthera Pharmaceuticals Inc. (stock ticker symbol ANTH). Also see all insider trading activities at Anthera Pharmaceuticals Inc.


Yearly summary of insider trading at Anthera Pharmaceuticals Inc (ANTH) by Odink Debra

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 ANTH 0 $0 1,205 $7,410 0 $0
2012 ANTH 0 $0 6,000 $41,485 0 $0
2011 ANTH 0 $0 0 $0 3,311 $4,999
2010 ANTH 1,000 $4,200 0 $0 0 $0


Insider trading of Anthera Pharmaceuticals Inc (ANTH) by Odink Debra

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-10-12 ANTH Sale 1,205 6.15 7,410
2012-03-01 ANTH Sale 2,000 6.57 13,140
2012-02-01 ANTH Sale 2,000 7.67 15,340
2012-01-10 ANTH Sale 800 6.51 5,205
2012-01-06 ANTH Sale 1,200 6.50 7,800
2011-04-13 ANTH Option Ex 3,311 1.51 4,999
2010-09-24 ANTH Buy 1,000 4.20 4,200

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Odink Debra (VP, Pharmaceutical R&D of Anthera Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.